When Novo Nordisk unveiled kidney outcomes data for its star GLP-1 medicine Ozempic last May, the company’s executive medical ...

Roche’s freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used in ...

The Trump administration’s executive order pausing foreign aid programs has sent crash waves through relief organizations ...

As Sandoz gears up to launch of one of the most anticipated biosimilars of the year, the company could face near-term ...

Just 11 days after AstraZeneca and Daiichi Sankyo gained FDA approval | The FDA has cleared AstraZeneca and Daiichi Sankyo's ...

On a quest to carve out a spot as one of the nuclear medicine greats, Massachusetts-based radiopharmaceutical specialist ...

To direct more attention toward the importance of regular breast cancer screenings, Novartis is taking to one of television’s ...